- CLINICAL BRIEFINGS
Through comprehensive genomic and immune analyses, mechanisms of lung cancer resistance after treatment with EGFR inhibition and vaccine therapy were investigated. This case report, together with data from the longitudinal lung cancer study TRACERx, highlight the importance of understanding when targeted variants are acquired during the cancer’s evolutionary history.
You Might Also Like
US PhD admissions shrink as fears over Trump’s cuts take hold
Many academic departments at US universities are planning to cut the size of graduate-student cohorts.Credit: Sophie Park/Bloomberg/GettyPhoenix-Avery Sarían has been...
Is academic research becoming too competitive? Nature examines the data
Success rates for Europe’s leading research grants are declining — some to single percentage points — as a surge in...
Aboveground biomass in Australian tropical forests now a net carbon source
Pan, Y. et al. The enduring world forest carbon sink. Nature 631, 563–569 (2024).Article ADS CAS PubMed Google Scholar Cox,...
The world’s first plastics treaty is in crisis: can it be salvaged?
Global consumption of plastics is on the rise, but only a small percentage of plastic waste is recycled. Credit: Justin...








